Tadalafil, a Phosphodiesterase-5 Inhibitor, Improves Erectile Dysfunction in Patients With Liver Cirrhosis

BACKGROUND: Erectile dysfunction(ED) is common in patients with chronic liver disease(CLD). Although it significantly worsens the quality of life, caregivers and researchers often neglect it. AIM: Evaluating the prevalence of ED in patients with CLD, associated factors, and response to therapy with...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Exp Hepatol
Auteurs principaux: Thakur, Jitender, Rathi, Sahaj, Grover, Sandeep, Chopra, Madhu, Agrawal, Swastik, Taneja, Sunil, Duseja, Ajay, Bhansali, Anil, Chawla, Yogesh K., Dhiman, Radha K.
Format: Artigo
Langue:Inglês
Publié: Elsevier 2019
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6637079/
https://ncbi.nlm.nih.gov/pubmed/31360023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2018.07.007
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires